Valuation: Seer, Inc.

Market Cap 119M 103M 96.1M 87.83M 166M 11.33B 168M 1.13B 442M 5.67B 446M 436M 18.87B P/E 2026 *
-2.07x
P/E 2027 * -2.2x
Enterprise Value 119M 103M 96.1M 87.83M 166M 11.33B 168M 1.13B 442M 5.67B 446M 436M 18.87B EV / Sales 2026 *
7.31x
EV / Sales 2027 * 5.67x
Free-Float
85.46%
Yield 2026 *
-
Yield 2027 * -
1 day-0.46%
1 week-3.57%
Current month-2.70%
1 month-0.46%
3 months+15.51%
6 months+22.03%
Current year+18.03%
1 week 2.14
Extreme 2.145
2.22
1 month 1.82
Extreme 1.82
2.25
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
2.88
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 01/03/2018
Director of Finance/CFO 58 01/05/2020
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 01/09/2020
Director/Board Member 76 01/12/2017
Director/Board Member 70 01/12/2017
Date Insider Type Main position Quantity % Market Cap.
28/07/26 Free

Director

41,500 0.0750%
28/07/26 Free

Director

41,500 0.0750%
28/07/26 Free

Director

31,125 0.0563%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%-3.57%-6.09%-22.58% 119M
-0.14%-1.21%+13.66%+14.62% 28.6B
+1.25%+2.97%+21.51%-3.78% 7.51B
-8.04%-4.90%+19.13%-45.79% 3.13B
-0.96%+31.05%+17.69%+98.15% 3.07B
+1.23%+3.13%+91.59%+79.63% 2.58B
-0.81%+27.55%+109.22%+112.74% 1.79B
-1.84%+15.70%+17.91%+17.82% 1.7B
+7.58%+14.44%+6.31%+49.72% 1.32B
+0.55%+5.82%-37.25%-25.96% 835M
Average -0.28%+1,426.26%+25.37%+27.46% 5.06B
Weighted average by Cap. -0.34%+1,862.14%+21.80%+20.25%

Financials

2026 *2027 *
Net sales 16.25M 14.07M 13.15M 12.02M 22.65M 1.55B 23M 154M 60.5M 775M 61.02M 59.69M 2.58B 20.95M 18.14M 16.95M 15.49M 29.2M 2B 29.65M 199M 78M 1B 78.67M 76.95M 3.33B
Net income -58.65M -50.77M -47.46M -43.37M -81.74M -5.59B -83.01M -557M -218M -2.8B -220M -215M -9.32B -55.7M -48.22M -45.07M -41.19M -77.62M -5.31B -78.84M -529M -207M -2.66B -209M -205M -8.85B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
10/08/26 $2.160 -0.46% 150,883
07/08/26 $2.170 -0.91% 268,261
06/08/26 $2.190 0.00% 381,376
05/08/26 $2.190 -0.90% 155,614
04/08/26 $2.210 -1.34% 288,226
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.160USD
Average target price
4.000USD
Spread / Average Target
+85.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock